Waystar Holding Corp. Common Stock
NASDAQ: WAY · HEALTHCARE · HEALTH INFORMATION SERVICES
Updated 2026-05-08
Waystar Holding Corp. Common Stock (WAY) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for WAY.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
WAY historical valuation range
Where current P/E sits in WAY's own 5Y range.
WAY intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
WAY valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 31.36x
P/S Ratio — History
Current: 3.48x
Is WAY overvalued in 2026?
Waystar Holding Corp. Common Stock (WAY) currently trades at $21.38 per share with a market capitalization of $4,029,989,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 63/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 31.4x, below its 5-year median of 41.7x.
Looking at its own history, WAY is currently trading cheaper than 82% of the last 5Y on P/E. This places it in the 18th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates WAY's intrinsic value at $25.87 per share, against the current market price of $21.38. This implies a margin of safety of +8.27%. The stock is priced close to its estimated fair value, offering limited upside without further operational improvement.
Financial quality is a concern. The Piotroski F-Score of 2/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: WAY trades at a fair valuation on our framework, with a Smart Value Score of 63/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is WAY overvalued in 2026?
Based on a Smart Value Score of 63/100, WAY is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is WAY's fair value?
Our DCF model estimates WAY's intrinsic value at $25.87 per share, versus the current price of $21.38. This produces a margin of safety of +8.27%.
What P/E ratio does WAY trade at?
WAY trades at a P/E of 31.4x on trailing twelve-month earnings, compared to its 5-year median of 41.7x.
Is WAY a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 63/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does WAY's valuation compare to its history?
On P/E, WAY currently sits in the 18th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is WAY's Smart Value Score?
WAY's Smart Value Score is 63/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.